Healthcare >> CEO Interviews >> November 2, 2003

Paul Goodson – Invitrogen Corporation (ivgn)

PAUL D. GOODSON has served as Vice President, Investor Relations of Invitrogen Corporation since January 2001. He came to Invitrogen from the Financial Relations Board, the world's largest investor relations agency, where he was a Senior Account Group Manager and a Director of its parent company, BSMG. Previously, he was Vice President of Investor Relations at ECA, Inc., a developer of advanced engine technologies and energy systems, and was later named President of that company. From 1983 to 1995, he held various positions in investor relations, marketing, research and environmental affairs at Pacific Enterprises, a large utility holding company, including the position of President of CERAC, Inc. In prior positions at Tosco, Energy Resources Company and TRW, he served as a lobbyist, senior scientist and process engineer. In 1980, Mr. Goodson co-founded Phytogen, a plant genetics firm in Pasadena, California, with one of his former Caltech professors. In 1983, he co- founded International Biotechnology Company, which worked to develop a single-dose hepatitis-B vaccine. He has served on the Boards of Directors of ECA and Quantum Group, Inc., a San Diego-based developer of carbon monoxide detection systems and other advanced chemical technologies. He holds a secret-level clearance from the US Department of Defense and a lifetime limited-service college teaching credential for chemistry and engineering from the State of California. He is an Adjunct Professor of Finance at the University of Phoenix and has taught Chemistry at El Camino Junior College in Gardena, California. Mr. Goodson holds BS and MS degrees in Chemical Engineering from Caltech (with honors) and the University of Wisconsin, respectively, and an MBA degree from UCLA. Profile
TWST: Would you begin with a history of Invitrogen and a picture of your

operations?

Mr. Goodson: This is literally a California garage story. It was founded

in 1987 by Lyle Turner and two